32 results
424B5
IKT
Inhibikase Therapeutics Inc
22 May 24
Prospectus supplement for primary offering
8:55am
business and predict our future success and viability;
The ongoing COVID-19 pandemic could materially affect our operations, as well as the business
424B5
IKT
Inhibikase Therapeutics Inc
1 Feb 24
Prospectus supplement for primary offering
4:49pm
future success and viability;
The ongoing COVID-19 pandemic could materially affect our operations, as well as the business or operations of third
424B3
mp7kf
4 Apr 23
Prospectus supplement
4:57pm
POS AM
hwcel
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
424B5
utklz9
16 May 22
Prospectus supplement for primary offering
9:47pm
S-3
93o7ani hig566zk
7 Feb 22
Shelf registration
12:00am
424B4
thr5t4 i9ykaz31y0
17 Jun 21
Prospectus supplement with pricing info
4:31pm